"Optimal Matching Between Lung Donor Organs of Marginal Quality and Recipients"
- Tuesday, January 25, 2022 - 2:00 pm to 3:00 pm EST

Presenters:
- Matthew Hartwig, MD, MHS • Associate Professor of Surgery, Duke University Health System, Durham, NC
- Sameep Sehgal, MD, FCCP • Staff Physician, Respiratory Institute, Cleveland Clinic, Cleveland, OH

Moderator:
- Deborah Levine, MD • Professor of Medicine, University of Texas Health Science Center, San Antonio, TX
- Norihisa Shigemura, MD, PhD • Professor of Surgery, Temple University Health System and Lewis Katz School of Medicine, Philadelphia, PA

AST would like to thank TCC COP for recommending this topic to include as part of the T3 webinar series.

Join us live on Wednesday, March 24, 2021, from 3:00 PM ET to 4:00 PM ET

Speakers:

• Jennifer Lai, MD, MBA • Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
• Mara McAdams DeMarco, PhD • Associate Professor, Johns Hopkins University, Baltimore, MD
• Evan Kransdorf, MD, PhD • Assistant Director, Heart Transplant Research and Education, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Moderator:

• Lianne Singer, MD, FRCPC • Professor of Medicine, University Health Network, University of Toronto, Toronto, ON

Speakers:
Kelly Schlendorf, MD, MHS • Assistant Professor of Medicine, Vanderbilt Heart and Vascular Institute, Nashville, TN
Marcelo Cypel MD, MSc, FACS, FRCSC • Associate Professor of Surgery, University of Toronto (UHN), Toronto, ON

Moderator:
Daniel Kaul, MD • Professor of Internal Medicine, University of Michigan, Ann Arbor, MI

After participating in this webinar, the attendee will be able to:

1. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for heart transplantation
2. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for lung transplantation
3. Describe future directions for utilization of HCV donors (NAT+/-) for thoracic organ transplantation

AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation."